Eli Lilly Launches Multi-Dose Zepbound Pen to Drive Obesity Drug Growth
Eli Lilly unveiled a new multi-dose version of its blockbuster obesity drug Zepbound, allowing patients to receive a full month of doses in a single injection.
More Videos
Go Fund Yourself: Strengthening Digital Identity and Human Connection
Verify Faces Inc. is building a secure identity verification platform. Plus, Ready & Forward on leading a national movement centered on service.
Inside Drew Brees’ Secret Weapon for Flexibility, Performance, and Longevity
Drew Brees and Tony Zaccario join us at the NYSE to discuss how Stretch Zone is transforming recovery, flexibility, and performance nationwide.
Five-Star Frenzy: The Hotels Redefining Luxury in 2026
Luxury travel is surging, with 2026 bookings up 30–40%. Forbes Travel Guide reveals new hotspots, five-star trends, and what’s driving the $181B boom.
The Floral Brand Disrupting Valentine’s Day Delivery
With $3B spent on Valentine’s flowers, UrbanStems CEO Meenakshi Lala shares trends, tech innovations, and how gifting is evolving for 2026.
The Real Estate Bets Paying Off in 2026 Aren’t the Obvious Ones
Rich Hill of Principal Asset Management breaks down where real estate capital is flowing, what’s driving returns, and how 2026 could reshape the market.
One Trend Quietly Dominated Super Bowl 60 Ads, and It’s a Game Changer
From surprise celebrity overload to fewer influencers, USA Today's Ralphie Aversa breaks down the biggest Super Bowl 60 ads and why AI quietly stole the show.
Bob’s Discount Furniture Goes Public: What This IPO Means for the Retail Market
Carl Lukach, CFO of Bob’s Discount Furniture, shares insights on the company’s IPO, growth strategy, and what it means for the future of the furniture market.
Robotaxis Vs. New York City: Can Self-Driving Cars Survive the Toughest Streets on Earth?
Waymo eyes NYC, the hardest city for robotaxis yet. Safety, laws, unions, and public trust collide as autonomous cars push toward America’s streets.
